Medications News

On-Line Intervention Reduces Suicide Risk in Veterans

December 5th, 2014
A new study suggests a brief online intervention may help veterans reduce the risk of suicide. In their research, psychologist from Florida State University developed a simple computer-based approach to treating anxiety sensitivity. They believe the software may provide significant benefit for veterans ...

Vitamin D Linked to Seasonal Depression

December 3rd, 2014
Although Vitamin D deficiency is commonly associated with bone and muscle weakness, new research suggests the vitamin may also be vital for mental health. University of Georgia researchers led an international study that found a link between seasonal affective disorder, or SAD, and ...

Omega 3/6 Lessens Symptoms of Inattentive ADHD Subtype

December 3rd, 2014
Many children and teens who have the inattentive subtype of attention-deficit hyperactivity disorder (ADHD) experience significant improvements after taking the fatty acid supplements omega 3 and 6 for several months, according to a dissertation at Sweden's Sahlgrenska Academy, University of Gothenburg. The findings ...

Mouse Study Suggest Meds to Restore Natural High may Avert Chronic Marijuana Use

December 2nd, 2014
Development of a medication to replenish the supply of a molecule that normally activates cannabinoid receptors in the brain may be an answer to relieve mood and anxiety disorders. Vanderbilt researchers believe this effect would enable some people to quit using marijuana. In ...

Imaging Studies Differentiate PTSD & Mild Brain Injury

December 2nd, 2014
New research suggests advanced brain imaging techniques can help to differentiate military veterans with post-traumatic stress disorder (PTSD) from those with mild traumatic brain injury (MTBI). Currently, it is difficult for clinicians to make a definitive diagnosis as symptoms for PTSD and MTBI ...

Placebo Treatment Activates Brain in Parkinson’s

November 27th, 2014
Researchers have learned that simply the expectation of learning stimulates brain activity among individuals with Parkinson’s. For individuals with Parkinson's disease, the placebo effect activates the brain, providing a response similar to that experienced after the administration of actual medications. Researchers say the study ...

Rat Study Suggests Schizophrenia May Stem from Surplus Brain Protein

November 25th, 2014
New research discovers a gene associated with schizophrenia also plays a role in brain development. The finding may help to explain the way the disease originates. Bonnie Firestein, Ph.D., a Rutgers professor in the Department of Cell Biology and Neuroscience, says too much ...

Anti-Anxiety, Sleep Drugs to Teens Comes with Abuse Risk

November 25th, 2014
New research discovers prescription of an anti-anxiety or sleeping medication to a teen comes with a risk of illegal abuse of medications by the teen. Experts say the findings suggest substance abuse assessments should be performed before the drugs are prescribed. University of Michigan ...

Prolonged Negative Thinking May Increase Alzheimer’s Risk

November 18th, 2014
Repetitive negative thinking (RNT) may increase a person's risk for developing Alzheimer’s disease, according to researchers from the Institute of Psychiatry, Psychology & Neuroscience at King’s College London. In Alzheimer’s disease, brain cells begin to degenerate and die, causing severe problems with memory ...

Rat Study Suggests Oxycodone Can Cause Long-term Behavioral Changes

November 18th, 2014
New research using a rat model suggests even brief usage of the painkiller oxycodone may impair behavior in a person even after use of the medication ends. Investigators believe use of oxycodone may result in a “cognitive hangover” that can lead to enduring ...